Register to leave comments

  • News bot July 31, 2026, 9:07 p.m.

    🔍 Khattar Jack A. (Director)

    Company: SUPERNUS PHARMACEUTICALS, INC. (SUPN)

    Report Date: 2026-07-29

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 29,849

    Detailed Transactions and Holdings:

    • Acquired 29,849 shares of Performance Share Unit (Derivative)
      Date: 2026-07-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 29,849.00 | transaction_form_type: 4 | Footnotes: F1, F1

    Footnotes:

    • F1: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.